Screen for Mutation within EXON 28 of VWF

Molecular Haematology


Description

Von Willebrand factor (VWF) is a multimeric glycoprotein found in plasma, subendothelium and platelets and synthesised by endothelial cells and megacaryocytes. A deficiency of VWF results in von Willebrand disease, the most common bleeding disorder found in humans and affecting up to 1% of some populations. VWD can be classified into three main categories; type 1 VWD is characterised by a quantitative deficiency inherited in an autosomal manner, type 3 VWD is the least common and is identified by very low or absent VWF and is inherited in an autosomal recessive mode; type 2 VWD is a qualitative deficiency where, although the protein may be present, it is functionally defective. Determination of causative mutation in patients with type 2 von Willebrand disease, by analysis of associated regions of the von Willebrand factor gene (type 2N; exons 18-23, type 2A and 2B; exon 28).


Sample Type

10ml citrate or EDTA blood less than 48 hours old.


Turnaround Time

Within 13 weeks


Testing Frequency

As required


Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.

Your contact for this test

team

Rosalie Ward BSc (Hons) Biomedical Science, MSc Pathological Science, FIBMS

Section Lead - Cellular Immunology/Cell Markers

You are enquiring about

Screen for Mutation within EXON 28 of VWF